Next Article in Journal
Non-Secretory Immunoglobulin E Myeloma Associated with Immunoglobulin G Monoclonal Gammopathy of Undetermined Significance
Previous Article in Journal
Thrombotic Microangiopathy Associated with Bortezomib Treatment in a Patient with Relapsed Multiple Myeloma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 4
Issue 2
10.4081/hr.2012.e12
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Transient Ischemic Attacks as the First Presentation of JAK2-V617F Positive Chronic Myeloproliferative Neoplasm

by
Fani Kalala
1,
Antigoni Mamara
1,
Maria Ioannou
2 and
Matthaios Speletas
1,*
1
Department of Immunology and Histocompatibility, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece
2
Department of Pathology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2012, 4(2), e12; https://doi.org/10.4081/hr.2012.e12
Submission received: 17 February 2012 / Revised: 14 April 2012 / Accepted: 14 April 2012 / Published: 29 June 2012

Abstract

Several studies have shown that thrombotic events may underlie a latent or subclinical myeloproliferative neoplasm (MPN) and precede its definite diagnosis by 1–2 years. An early diagnosis of patients with MPN, especially those with thrombotic events in the latent MPN phase, would be beneficial for their management, preventing further morbidity and improving their quality of life. For the majority of these cases, the location of thrombosis is mainly in the splanchnic major veins, while ischemic stroke and cerebral venous thrombosis are rarely observed. In this report, we present a female patient with transient ischemic attacks who suffered from a latent MPN, on the basis of a positive testing for the JAK2-V617F mutation.
Keywords: TIAs; latent myeloproliferative neoplasm; JAK2-V617F TIAs; latent myeloproliferative neoplasm; JAK2-V617F

Share and Cite

MDPI and ACS Style

Kalala, F.; Mamara, A.; Ioannou, M.; Speletas, M. Transient Ischemic Attacks as the First Presentation of JAK2-V617F Positive Chronic Myeloproliferative Neoplasm. Hematol. Rep. 2012, 4, e12. https://doi.org/10.4081/hr.2012.e12

AMA Style

Kalala F, Mamara A, Ioannou M, Speletas M. Transient Ischemic Attacks as the First Presentation of JAK2-V617F Positive Chronic Myeloproliferative Neoplasm. Hematology Reports. 2012; 4(2):e12. https://doi.org/10.4081/hr.2012.e12

Chicago/Turabian Style

Kalala, Fani, Antigoni Mamara, Maria Ioannou, and Matthaios Speletas. 2012. "Transient Ischemic Attacks as the First Presentation of JAK2-V617F Positive Chronic Myeloproliferative Neoplasm" Hematology Reports 4, no. 2: e12. https://doi.org/10.4081/hr.2012.e12

APA Style

Kalala, F., Mamara, A., Ioannou, M., & Speletas, M. (2012). Transient Ischemic Attacks as the First Presentation of JAK2-V617F Positive Chronic Myeloproliferative Neoplasm. Hematology Reports, 4(2), e12. https://doi.org/10.4081/hr.2012.e12

Article Metrics

Back to TopTop